Impact of GLP-1 receptor agonists on gastrointestinal function and symptoms
{{output}}
Introduction: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are approved for diabetes, obesity, and metabolic liver disease, but are also used off-label for other conditions. Adverse events associated with GLP-1RAs have be... ...
